THURSDAY, Sept. 19, 2024 -- For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer...
Vous n'êtes pas connecté
FRIDAY, Sept. 20, 2024 -- Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk muscle-invasive urothelial carcinoma after radical surgery, according to a study published online...
THURSDAY, Sept. 19, 2024 -- For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer...
THURSDAY, Sept. 19, 2024 -- For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by...
TUESDAY, Sept. 17, 2024 -- A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with...
FRIDAY, Sept. 27, 2024 -- Omitting biopsy in patients with negative magnetic resonance imaging (MRI) results is associated with a significantly...
FRIDAY, Sept. 20, 2024 -- For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left...
MONDAY, Sept. 23, 2024 -- The incidence of a composite cardiovascular disease (CVD) end point is increased among older adults with cancer, especially...
FRIDAY, Sept. 27, 2024 -- An in-home, voice-activated cognitive behavioral therapy (CBT) program improves insomnia symptoms among breast cancer...
WEDNESDAY, Sept. 18, 2024 -- For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced...
TUESDAY, Sept. 17, 2024 -- For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with...
FRIDAY, Sept. 20, 2024 -- For veterans with incident chronic kidney disease (CKD), a history of homelessness is associated with an increased risk for...